{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:18:54Z","timestamp":1794277134785,"version":"4.9.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2019XK320037"],"award-info":[{"award-number":["2019XK320037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Respiratory involvement is common in immunoglobulin G4-related disease (IgG4-RD). However, severe asthma as the initial clinical manifestation of IgG4-RD is rare and  might be neglected by respiratory clinicians. We aimed to explore the clinical characteristics and prognoses of patients with immunoglobulin G4-related disease (IgG4-RD) manifesting as severe asthma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of\u00a0the clinical characteristics and prognoses of patients with severe asthma who were eventually diagnosed with IgG4-RD was performed in the Peking Union Medical College Hospital from 2013 to 2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twelve patients (5males, 7 females) were included. The mean age at enrollment and age of asthma onset were 59.4\u2009\u00b1\u200910.1 and 53.8\u2009\u00b1\u200910.4\u00a0years, respectively. The mean duration of asthma symptoms was 5.7\u2009\u00b1\u20092.0\u00a0years. In all patients, the proportion (25.1\u2009\u00b1\u200910.3%) and count (2.0\u2009\u00b1\u20091.1)\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L of eosinophils in peripheral blood increased. Additionally, all patients exhibited elevated total immunoglobulin E [IgE, (1279.3\u2009\u00b1\u20091257.9) KU\/L] and IgG4 (9155.8\u2009\u00b1\u20099247.6) mg\/dL. Bronchial wall thickening (n\u2009=\u200911) and mediastinal\/hilar lymphadenopathy (n\u2009=\u200911) were major chest CT manifestations. All were pathologically diagnosed through surgical biopsy; submandibular gland (n\u2009=\u20098), supraclavicular lymph node (n\u2009=\u20092), stomach (n\u2009=\u20091), rashes (n\u2009=\u20091), lacrimal gland (n\u2009=\u20091) and thoracoscopic lung (n\u2009=\u20091) biopsies were performed. Asthma was well controlled by oral glucocorticoids (GCs), but some patients relapsed during tapering (n\u2009=\u200911). The refractory condition was controlled after increasing the dosage of GCs and add-on immunosuppressants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For patients with middle age-onset severe asthma with elevated eosinophils, total IgE and IgG4 levels and available salivary gland ultrasound imaging, ruling out IgG4-RD is recommended. GCs used in combination with immunosuppressants is recommended to prevent relapse.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-01937-9","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:02:56Z","timestamp":1649746976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Severe asthma as the initial clinical manifestation of IgG4-related disease: a retrospective clinical study"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiangning","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"1937_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343\u201373.","journal-title":"Eur Respir J"},{"key":"1937_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rmed.2018.10.020","volume":"145","author":"A von Bulow","year":"2018","unstructured":"von Bulow A, Backer V, Bodtger U, S\u00f8es-Petersen NU, Vest S, Steffensen I, et al. Differentiation of adult severe asthma from difficult-to-treat asthma\u2014outcomes of a systematic assessment protocol. Respir Med. 2018;145:41\u20137.","journal-title":"Respir Med"},{"key":"1937_CR3","doi-asserted-by":"publisher","first-page":"m1067","DOI":"10.1136\/bmj.m1067","volume":"369","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020;369:m1067.","journal-title":"BMJ"},{"key":"1937_CR4","first-page":"644","volume":"56","author":"PP Zhang","year":"2017","unstructured":"Zhang PP, Zhao JZ, Wang M, Feng RE, Liu XW, Lai XM, et al. The clinical characteristics of 346 patients with IgG4-related disease. Zhonghua Nei Ke Za Zhi. 2017;56:644\u20139.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"1937_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"1937_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1056\/NEJMra1608969","volume":"377","author":"E Israel","year":"2017","unstructured":"Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377:965\u201376.","journal-title":"N Engl J Med"},{"key":"1937_CR7","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1513\/AnnalsATS.201403-128FR","volume":"11","author":"SN Campbell","year":"2014","unstructured":"Campbell SN, Rubio E, Loschner AL. Clinical review of pulmonary manifestations of IgG4-related disease. Ann Am Thorac Soc. 2014;11:1466\u201375.","journal-title":"Ann Am Thorac Soc"},{"key":"1937_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77\u201387.","journal-title":"Ann Rheum Dis"},{"key":"1937_CR9","doi-asserted-by":"publisher","first-page":"e2150","DOI":"10.1097\/MD.0000000000002150","volume":"94","author":"YY Fei","year":"2015","unstructured":"Fei YY, Shi JH, Lin W, Chen Y, Feng RE, Wu QJ, et al. Intrathoracic involvements of immunoglobulin G4-related sclerosing disease. Medicine (Baltimore). 2015;94:e2150.","journal-title":"Medicine (Baltimore)"},{"key":"1937_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1183\/09031936.00025211","volume":"39","author":"JH Ryu","year":"2012","unstructured":"Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur Respir J. 2012;39:180\u20136.","journal-title":"Eur Respir J"},{"key":"1937_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.rmed.2017.10.005","volume":"132","author":"JP Corcoran","year":"2017","unstructured":"Corcoran JP, Culver EL, Anstey RM, Talwar A, Manganis CD, Cargill TM, et al. Thoracic involvement in IgG4-related disease in a UK-based patient cohort. Respir Med. 2017;132:117\u201321.","journal-title":"Respir Med"},{"key":"1937_CR12","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen Y, Inoue D, Kitao A, Onodera M, Abo H, Miyayama S, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33:1886\u201393.","journal-title":"Am J Surg Pathol"},{"key":"1937_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/s10165-011-0504-x","volume":"22","author":"S Matsui","year":"2012","unstructured":"Matsui S, Taki H, Shinoda K, Suzuki K, Hayashi R, Tobe K, et al. Respiratory involvement in IgG4-related Mikulicz\u2019s disease. Mod Rheumatol. 2012;22:31\u20139.","journal-title":"Mod Rheumatol"},{"key":"1937_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1378\/chest.12-2954","volume":"143","author":"N Srivali","year":"2013","unstructured":"Srivali N, Ratanapo S, Ungprasert P, Cheungpasitporn W. Significance of lymphadenopathy in IgG4-related sclerosing disease and sarcoidosis. Chest. 2013;143:1191\u20132.","journal-title":"Chest"},{"key":"1937_CR15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/resp.12599","volume":"20","author":"T Ogoshi","year":"2015","unstructured":"Ogoshi T, Kido T, Yatera K, Oda K, Nishida C, Yamasaki K, et al. Incidence and outcome of lung involvement in IgG4-related autoimmune pancreatitis. Respirology. 2015;20:1142\u20134.","journal-title":"Respirology"},{"key":"1937_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.anai.2015.12.003","volume":"116","author":"M Baqir","year":"2016","unstructured":"Baqir M, Garrity JA, Vassallo R, Witzig TE, Ryu JH. Asthma and orbital immunoglobulin G4-related disease. Ann Allergy Asthma Immunol. 2016;116:313\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1937_CR17","first-page":"193","volume":"40","author":"GJ Han","year":"2017","unstructured":"Han GJ, Hu H, Mao D, Bai X, She DY, Zhao SF, et al. IgG4-related lung disease: analysis of 8 cases and literature review. Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:193\u20138.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"1937_CR18","first-page":"3442","volume":"98","author":"M Wu","year":"2018","unstructured":"Wu M, Wang L, Shang GG, Hong QY. Clinical analysis of IgG4-related lung disease. Zhonghua Yi Xue Za Zhi. 2018;98:3442\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"1937_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2019.06.010","volume":"66","author":"AT Morales","year":"2019","unstructured":"Morales AT, Cignarella AG, Jabeen IS, Barkin JS, Mirsaeidi M. An update on IgG4-related lung disease. Eur J Intern Med. 2019;66:18\u201324.","journal-title":"Eur J Intern Med"},{"key":"1937_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/14397595.2018.1548089","volume":"29","author":"S Matsui","year":"2019","unstructured":"Matsui S. IgG4-related respiratory disease. Mod Rheumatol. 2019;29:251\u20136.","journal-title":"Mod Rheumatol"},{"key":"1937_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0039-1700995","volume":"41","author":"MC Moura","year":"2020","unstructured":"Moura MC, Gripaldo R, Baqir M, Ryu JH. Thoracic involvement in IgG4-related disease. Semin Respir Crit Care Med. 2020;41:202\u201313.","journal-title":"Semin Respir Crit Care Med"},{"key":"1937_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12890-016-0181-9","volume":"16","author":"XF Sun","year":"2016","unstructured":"Sun XF, Liu HR, Feng RE, Peng M, Hou XM, Wang P, et al. Biopsy-proven IgG4-related lung disease. BMC Pulm Med. 2016;16:20.","journal-title":"BMC Pulm Med"},{"key":"1937_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2332\/allergolint.11-CR-0352","volume":"61","author":"S Ito","year":"2012","unstructured":"Ito S, Ko SBH, Morioka M, Imaizumi K, Kondo M, Mizuno N, et al. Three cases of bronchial asthma preceding IgG4-related autoimmune pancreatitis. Allergol Int. 2012;61:171\u20134.","journal-title":"Allergol Int"},{"key":"1937_CR24","doi-asserted-by":"publisher","first-page":"e1916","DOI":"10.1097\/MD.0000000000001916","volume":"94","author":"J London","year":"2015","unstructured":"London J, Martin A, Soussan M, Badelon I, Gille T, Uzunhan Y, et al. Adult onset asthma and periocular xanthogranuloma (AAPOX), a rare entity with a strong link to IgG4-related disease: an observational case report study. Medicine (Baltimore). 2015;94:e1916.","journal-title":"Medicine (Baltimore)"},{"key":"1937_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.rmed.2016.01.014","volume":"112","author":"T Flament","year":"2016","unstructured":"Flament T, Marchand-Adam S, Gatault P, Dupin C, Diot P, Guilleminault L. What are the characteristics of asthma patients with elevated serum IgG4 levels? Respir Med. 2016;112:39\u201344.","journal-title":"Respir Med"},{"key":"1937_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12890-019-0957-9","volume":"19","author":"XL Wang","year":"2019","unstructured":"Wang XL, Wan J, Zhao L, Da JP, Cao B, Zhai ZG. IgG4-related disease with tracheobronchial miliary nodules and asthma: a case report and review of the literature. BMC Pulm Med. 2019;19:191.","journal-title":"BMC Pulm Med"},{"key":"1937_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jamadermatol.2019.4260","volume":"156","author":"C Wu","year":"2020","unstructured":"Wu C, Zeng YP. Mikulicz disease. JAMA Dermatol. 2020;156:451.","journal-title":"JAMA Dermatol"},{"key":"1937_CR28","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Mattoo H, Mahajan VS, Kulikova M, Lu L, Deshpande V, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016;55:1000\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"1937_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00296-019-04409-2","volume":"40","author":"I Asproudis","year":"2020","unstructured":"Asproudis I, Kanari M, Ntountas I, et al. Successful treatment with rituximab of IgG4-related disease coexisting with adult-onset asthma and periocular xanthogranuloma. Rheumatol Int. 2020;40:671\u20137.","journal-title":"Rheumatol Int"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-01937-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:05:34Z","timestamp":1649747134000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-01937-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-01937-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Peking Union Medical College Hospital (No. JS-2517) in accordance with the principles of the Declaration of Helsinki. Informed consent was signed by the patients or their authorized family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As any identifiable information (image, face, name etc.) of all enrolled cases is not revealed in the submission, for that Consent is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}